Investigation Overview
August 17, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of ADMA Biologics Inc (NASDAQ:ADMA) was announced over potential breaches of fiduciary duties by certain officers and directors at ADMA Biologics. The investigation by a law firm concerns whether certain ADMA Biologics officers and directors breached their fiduciary duties ...
You must register (for free) or login to view the entire investigation.